Clinical Trials Browser

Phase 2 × Liver Neoplasms × Docetaxel × Clear all

NCT00006010 2016-12-07

Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms